Merit Medical Systems, Inc. (MMSI)
NASDAQ: MMSI · Real-Time Price · USD
90.76
+0.26 (0.29%)
Aug 14, 2026, 4:00 PM EDT - Market closed

Merit Medical Systems Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
1,5791,5161,3571,2571,1511,075
Revenue Growth
10.19%11.75%7.89%9.24%7.09%11.50%
Gross Profit
781.73738.27643.33583.87519.1485.33
Operating Income
214.55193.9168.04135.07108.2684.4
Net Income
145.56128.49120.3694.4174.5248.45
Earnings Per Share
2.432.132.031.621.290.84
EPS Growth
23.23%4.93%25.31%25.58%53.57%-

Revenue by Segment

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Peripheral Intervention
-579.84532.77502.22439.81405.12
Cardiac Intervention
-448.91368.95358.45343.19320.64
Custom Procedural Solutions
-209.33200.03195.33190.19193.94
OEM
-204.96199.99164.56145.03123.53
Endoscopy
-72.8654.7736.8132.7631.52
Revenue (Total)
1,5791,5161,3571,2571,1511,075

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
448.7446.4376.72588.5458.4167.75
Total Debt
820.12821.57794.67891.36268.75316.48
Net Cash (Debt)
-371.42-375.17-417.95-302.82-210.34-248.73
Net Cash Growth
------
Net Cash Per Share
-6.19-6.21-7.04-5.19-3.65-4.34

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
283.45297.37220.8145.15114.29147.23
Capital Expenditures
-80.24-81.72-35.14-34.29-45.03-27.94
Free Cash Flow
203.21215.66185.66110.8669.26119.29
Free Cash Flow Growth
5.66%16.16%67.47%60.06%-41.94%0.01%

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
49.51%48.70%47.42%46.44%45.10%45.16%
Operating Margin
13.59%12.79%12.39%10.74%9.41%7.85%
Pretax Margin
12.32%11.28%11.06%8.91%7.18%5.02%
Profit Margin
9.22%8.48%8.87%7.51%6.47%4.51%
FCF Margin
12.87%14.23%13.69%8.82%6.02%11.10%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
37.3440.6746.8346.4653.9472.59
Forward PE
20.8122.5127.1324.0425.9727.70
P/FCF Ratio
26.6724.2330.3639.5758.0429.49
PS Ratio
3.433.454.163.493.493.27